Partial or total penectomy with inguinal and/or pelvic lymph node dissection + PEMBROLIZUMAB + PYRUVATE CARBOXYLASE, MITOCHONDRIAL for penile neoplasms
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
9 Apr 2024: Trial registered, NCT06353906
13 Aug 2024: Trial started, NCT06353906
The trials
NCT06353906: Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
State
Under way
Phase
Phase 2
People
27 planned
Started
13 Aug 2024
Primary completion
14 Oct 2026
Arms
Induction chemo-immunotherapy combination followed by consolidative surgical resection
Results
None posted
9 Apr 2024: Trial registered
13 Aug 2024: Trial started
How the status changed
19 Nov 2026: First set: Phase 2 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.